Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2026-02-22 @ 5:22 PM
Study NCT ID:
NCT00482495
Status:
COMPLETED
Last Update Posted:
2011-05-11
First Post:
2007-06-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Mayo Clinic
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000546757
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Suzanne R. Hayman, M.D.
Old Organization:
Mayo Clinic
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |